Target intelligence / Profile preview

Ribosomal protein L5 pseudogene 3 (RPL5P3)

Target: RPL5P3
Molecular classification: Other (Pseudogene; not an enzyme, receptor, channel, transporter, or transcription factor)

Overview

Ribosomal protein L5 pseudogene 3 (RPL5P3) is a processed pseudogene in the human genome, meaning it derives from the functional ribosomal protein L5 gene (RPL5) but does not produce a functional protein. Pseudogenes like RPL5P3 typically arise from duplication or retrotransposition events and accumulate mutations that prevent them from encoding a protein. RPL5P3 does not play a role in any known biological pathways, is not considered a therapeutic target, and has no direct links to disease or drug interactions. Information and disease associations relevant to ribosomal protein L5 refer to the parent gene RPL5—not to RPL5P3[1][2][3][4].

Other names: HsT18216RPL5_13_1449RPL5P3

Beyond the preview

Go deeper on Ribosomal protein L5 pseudogene 3 (RPL5P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L5 pseudogene 3 (RPL5P3).

Explore the full profile